Results 81 to 90 of about 1,469 (156)

Effect of growth hormone replacement therapy in a boy with Dent's disease: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Dent's disease is an X-linked recessive proximal tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis and progressive renal failure.
Ludwig Michael   +3 more
doaj   +1 more source

Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis

open access: yesKidney International, 1997
The annual urinary screening of Japanese children above three years of age has identified a progressive renal tubular disorder characterized by low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. The disorder has been observed in over 60 patients and has a familial predisposition.
Akuta, N   +7 more
openaire   +3 more sources

Long-term recombinant human growth hormone therapy in Dent’s disease type 1

open access: yesEndokrynologia Polska
Not required for Clinical Vignette.
Miao Huang   +5 more
doaj   +1 more source

Dent’s disease: case series from a single center

open access: yesThe Turkish Journal of Pediatrics
Background. Dent’s disease (DD) is a rare X-linked recessive tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis/nephrolithiasis and chronic kidney disease.
Hilal Yaşar   +5 more
doaj   +1 more source

Bioinformatics analysis of a <i>CLCN5</i> geneframeshift mutation in a patient with Dent disease. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban
Zhang Y, Li N, Fan L, Liu J.
europepmc   +1 more source

Coexisting genetic kidney disease explains many cases of 'familial' IgA nephropathy where the proband has biopsy-confirmed mesangial IgA deposits. [PDF]

open access: yesFront Med (Lausanne)
Li Y   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy